Astron Research Limited, a leading IP oriented pharma contract research organization, is a fast growing Pharma Contract Research Organisation (CRO) with a strong quest to deliver best services to the rapidly growing Healthcare industry and has embarked its presence as a prominent global CRO. The Company was established in the year 2001 with an objective to provide prompt and reliable services to Pharma sector worldwide and improve the product quality with the help of Technological Innovations and Upgradations. Astron commenced its UK operations in 2004 for Quality Testing and QP Release of finished formulations and API. This facility is now UK-MHRA approved. The Company has products and technology are sold in over 50 countries, which includes European Union, US, Canada Australia, New Zealand, South Africa, Brazil, Mexico, Middle East & North African countries. 45 ANDAs filed in US and 64 EU CTD dossiers developed till 2010. The Global turnover registered a growth of 40% in the current financial year with the contribution of European market being 50%. The company is capable of handling Formulation and Analytical Research of Solid Orals, Injectables, Lyophilised injectables, Topicals, Effervescent tablets, Specialty medicaments like Potent drugs & Oncology products. The company has also acquired expertise in oral NDDS and Controlled Release pellets. The Company has around 300 Research Professionals working on various drug products and the departments of work force include:Research & Development, Project Co-ordination, Regulatory Support, Business Development, Market support & Customer service, Liaisons and Logistics.
Phone: 442088631034
Fax: 442084273450
Add：Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4H
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
